CDH16 and carcinoma: This is largely consistent with RNA expression data from The Cancer Genome Atlas Research Network (https://www.cancer.gov/tcga), suggesting overwhelmingly high rates and levels of CDH16 expression in renal cell carcinomas and—less frequently and at lower levels—in carcinomas of the thyroid, endometrium, ovary, and the uterine cervix.